Isbn: 9780521563086 - networks of innovation: vaccine development at merck, sharp and dohme, and mulford, 1895-1995 (6 Ergebnisse)

Zustand: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc.

Zustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

First Edition. Near fine cloth copy in a near-fine, very slightly edge-nicked and dust-dulled dust-wrapper. Remains particularly well-preserved overall; tight, bright, clean and strong. Physical description: xi, 273 pages; 24 cm. Subjects: Merck, Sharp & Dohme International History; H. K. Mulford Company History; Sharp & Dohme (Firm) History; Merck & Co. History; Merck, Sharp and Dohme (Firm); Vaccines History; Vaccines industry History; Vaccination United States Research History; Pharmaceutical industry United States History; Vaccines. 1 Kg.…

Hardcover. Zustand: Very Good. Zustand des Schutzumschlags: Very Good. First Edition. Publisher's hardback in better than very good condition: firm and square, strong joints. Complete with original dustjacket, not showing any tears or chips. Contents tight and clean; no pen-marks. Not from a library so no such stamps or labels. Thus a tidy book in very presentable condition.…

Hardcover. Zustand: Fine. Zustand des Schutzumschlags: Fine. First edition. Fine in fine dustwrapper.

8vo. 273, [1] pp. Index. Blue silver-stamped cloth, dust jacket. INSCRIBED by both authors, with Christmas card "Lots of love to the family, Jane and Lou". Fine. ISBN: 0521563089 "Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals." â" Cambridge University Press.…